ID
13816
Beschrijving
This study evaluates the effectiveness and safety of MFNS in improving the Treatment of Chronic Sinusitis. ODM derived from:"Randomized Double-blind Clinical Trial on the Efficacy and Safety of 200 mcg BID Mometasone Furoate Nasal Spray (MFNS) or Placebo in the Treatment of Chronic Sinusitis". Leader of the clinical trial: Prof. Dr. med. Karl Hörmann Direktor der Hals-Nasen-Ohren-Klinik / Clinic Director Ear, Nose and Throat Clinic Medical Faculty Mannheim Heidelberg University at the University Medical Centre Mannheim Theodor-Kutzer-Ufer 1-3 68167 Mannheim
Trefwoorden
Versies (2)
- 08-03-16 08-03-16 -
- 20-09-21 20-09-21 -
Geüploaded op
8 maart 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Study schedule - Clinical Trial on the Efficacy and Safety BID Mometasone Furoate Nasal Spray (MFNS) in the Treatment of Chronic Sinusitis
Study schedule
- StudyEvent: ODM
Beschrijving
Concomitant medication
Beschrijving
Admissable Concomitant medication
Datatype
integer
Alias
- UMLS CUI [1]
- C2347852
Beschrijving
The following drugs may not be used prior to initial examination, and may also not be used during the trial.
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0683610
- UMLS CUI [1,2]
- C0013227
Similar models
Study schedule
- StudyEvent: ODM
C0278350 (UMLS CUI-2)
C0489531 (UMLS CUI-3)
C0014245 (UMLS CUI-2)
C0031809 (UMLS CUI-2)
C0037199 (UMLS CUI-2)
C1145675 (UMLS CUI-2)
C0013227 (UMLS CUI [1,2])
C0003360 (UMLS CUI-2)
C0003360 (UMLS CUI-2)
C0003360 (UMLS CUI-2)
C0595724 (UMLS CUI-3)
C0081408 (UMLS CUI-5)